Skip to content
Search

Latest Stories

India likely to revive mega missile deal with Israel

The Indian army and the government are discussing ways to revive a $500 million order to buy Spike anti-tank guided missiles from Israel's state-owned defence contractor Rafael, military chief Bipin Rawat said Friday.

India recently called off the deal to procure 8,000 missiles, souring the build up to Israel Prime Minister Benjamin Netanyahu's visit to the country this week.


Rawat said the deal was scrapped after the state-run Defence Research and Development Organisation (DRDO) offered to manufacture similar missiles in line with premier Narendra Modi's pet 'Make in India' initiative.

"They (DRDO) said... why you are going for a missile that we are capable of manufacturing and can give you better results," Rawat said.

"That is what led to retracting of the RFP (request for proposal)."

Rawat said the DRDO missiles were yet to be tested and would not be ready till 2022, which could hit India's operational capabilities in the interim.

"So how do we bridge the gap between now and 2022? It's through the Spike.

"Rather than going whole hog we are in the discussion with the government" to fill in the gap he said.

"We can possibly look at a lesser number to meet the gap."

India has been investing tens of billions of dollars in updating its Soviet-era military hardware to counter long-standing tensions with regional rivals China and Pakistan.

Israel is a major weapons supplier to India, exporting an average of $1 billion of military equipment each year.

In April last year the two countries signed a military deal worth nearly $2 billion which includes the supply of medium-range surface-to-air missiles, launchers and communications technology.

But Modi has said he wants to end India's status as the world's number one defence importer and to have 70 percent of hardware manufactured domestically by the turn of the decade.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less